Head-to-head · computed 2026-08-11
Luvo Health vs MEDVi
Luvo Health: Luvo Health publishes an openly available price ladder for compounded GLP-1s — semaglutide and tirzepatide — alongside longevity peptides. It names four dispensing pharmacy partners. Its 52-week (annual) plan offers the lowest per-month-equivalent rate; no-commitment 4-week terms cost materially more. MEDVi: MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
Tirzepatide
| Luvo Health | MEDVi | |
|---|---|---|
| All-in maintenance | $339/mo | $399/mo |
| Best plan rate | $291/mo | $399/mo |
| 12-month total | $3,492 | $4,788 |
| Status | Reported · 2026-08-08 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Luvo Health's $339 a month undercuts MEDVi's $399 by $60 a month at the 10 mg/wk maintenance basis — $720 across a year. Luvo Health's figure is reported (captured 2026-08-08) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Luvo Health's tirzepatide ladder runs $339 a month billed monthly, and $291 a month on a twelve-month plan. MEDVi's runs $399 a month billed monthly. On the twelve-month basis Luvo Health's $3,492 beats MEDVi's $4,788 by $1,296 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| Luvo Health | MEDVi | |
|---|---|---|
| All-in maintenance | $249/mo | $299/mo |
| Best plan rate | $194/mo | $299/mo |
| 12-month total | $2,328 | $3,588 |
| Status | Reported · 2026-08-08 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Luvo Health's $249 a month undercuts MEDVi's $299 by $50 a month at the 2.4 mg/wk maintenance basis — $600 across a year. Luvo Health's figure is reported (captured 2026-08-08) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Luvo Health's semaglutide ladder runs $249 a month billed monthly, and $194 a month on a twelve-month plan. MEDVi's runs $299 a month billed monthly. On the twelve-month basis Luvo Health's $2,328 beats MEDVi's $3,588 by $1,260 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, MEDVi is dose-flat — the price survives titration — while Luvo Health's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Luvo Health
- MembershipNone
- Dose policyPer 4-week term; annual plan rate is total divided by 12 calendar months (13 cycles per year)
- Commitment52-week (annual) plan billed as lump-sum ($3,497 tirz / $2,327 sema) OR 4-week rolling ($339/$249 per term, no commitment)
- CancellationNo-commitment 4-week option available; confirm annual plan refund terms
- PharmacyFour named dispensing compounding pharmacies (specific names per provider materi
MEDVi
- MembershipNone
- Dose policyTiered on semaglutide; tirzepatide flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
What our desk is watching on each
Luvo Health: Luvo publishes plan-TERM totals in weeks, not monthly prices; our monthly figures divide the term total by 12 calendar months, but 52 weeks = 13 four-week cycles, so the true per-cycle cost is slightly different. Luvo makes no third-party testing claim and its own evaluation does not include lab testing. Geographic availability is a qualified all-50-states claim. Reported status — RangeYourself verified 2026-08-08.
MEDVi: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Questions people ask
Is Luvo Health or MEDVi cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Luvo Health vs MEDVi miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Luvo Health and MEDVi cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $3,492 at Luvo Health and $4,788 at MEDVi — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Luvo Health · MEDVi. Official sites: Luvo Health ↗ · MEDVi ↗. Nothing here is medical advice.